$LMAT

Thrivent Financial for Lutherans Grows Stock Holdings in LeMaitre Vascular, Inc. $LMAT

Thrivent Financial for Lutherans significantly increased its stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT) by 492.0% in the fourth quarter, now owning 88,950 shares valued at $7.21 million. The article also details other institutional investor activity, LeMaitre Vascular's financial performance, recent insider selling, and current analyst ratings, with the stock holding a "Moderate Buy" consensus.

Original reporting
MarketBeat · MarketBeat
Published May 21, 2026, 8:27 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 21, 2026, 9:00 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Thrivent Financial for Lutherans Grows Stock Holdings in LeMaitre Vascular, Inc. $LMAT — source image
Decision brief

The 30-second read

$LMATBullishHigh
01

Why it matters

The surge in holdings and positive analyst ratings suggest a bullish outlook, potentially leading to upward price movement.

02

Market read

The news indicates strong institutional support for LMAT, which could influence short to medium-term trading strategies.

03

What to watch

Potential regulatory changes or earnings disappointments could negate positive sentiment; macroeconomic factors may also influence stock performance.

Timing: short-term (next 1-3 months)

Background

Thrivent Financial increased its stake in LeMaitre Vascular significantly, signaling institutional confidence amidst stable financial performance.

Company-level read

Ticker impact

$LMATBullishHigh confidence
Context

The article reports a significant increase in institutional holdings and positive analyst ratings, indicating potential bullish sentiment.

Expected impact

Moderate upward price movement over the next 1-3 months.

Evidence & confidence

Institutional accumulation often precedes positive price trends, and current analyst ratings are favorable.

$LMATBullishHigh confidence
Context

The news is directly related to LeMaitre Vascular, Inc., affecting its stock outlook.

Expected impact

Potential for short to medium-term gains.

Evidence & confidence

Institutional buying and analyst upgrades are strong indicators of positive momentum.

Market effects

The medical devices sector may experience increased investor interest due to positive sentiment around healthcare equipment companies.

Limited regional impact; primarily affects US-based healthcare stocks.

Moderate; sector-specific news with potential influence on global healthcare indices.

Counterpoint

The recent increase in institutional holdings may have already been priced in, and short-term profit-taking could occur.

Key entities

  • Thrivent Financial for Lutherans

    A major institutional investor increasing its stake in LMAT.

  • LeMaitre Vascular, Inc.

    A healthcare company specializing in medical devices for vascular procedures.

Related articles

$LMATHigh

LEMAITRE VASCULAR INC (LMAT): Results of Operations and Financial Condition

LEMAITRE VASCULAR INC (LMAT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d320964dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 LeMaitre Q2 2026 Financial Results BURLINGTON, MA, August 4, 2026 – LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q2 2026 results, announced a quarterly divid

$NVDAMed

Nvidia to Invest Up to $3 Billion in Blackstone

The Information reported Nvidia plans to invest up to $3 billion in Lancium, a Blackstone-backed power and data center infrastructure developer tied to the Stargate AI initiative. Nvidia would initially put in $2 billion for a 20% stake, with up to $1 billion more contingent on performance thresholds. No company comment was provided.

$NVDAMed

Nvidia to invest up to US$3 billion in Stargate data centre developer Lancium: The Information

Nvidia plans to invest up to $3 billion in Lancium, the developer of the Stargate data center campus in Texas, The Information reported. Nvidia would invest $2 billion for about a 20% stake, with an additional $1 billion possible based on grid hookup thresholds. Lancium’s land and power portfolio has an enterprise value near $10 billion, and it may explore an IPO in 2027.

$USARMed

Is USA Rare Earth (USAR) Overvalued On Its DOE Funding And Tokenization Buzz?

Simply Wall St says USA Rare Earth (USAR) shares have rebounded after being selected by the U.S. Department of Energy for up to $19.3M in federal funding, pending final negotiations, for a pilot-scale rare earth separations project. The article cites mixed valuation views, with a “fair value” of $0.33 versus a DCF estimate of $83.09, and notes recent price returns.